A multicenter study of the efficacy of the ketogenic diet

E P Vining1, J M Freeman, K Ballaban-Gil

  • 1The Johns Hopkins Medical Institutions, Baltimore, MD 21287-7247, USA.

Archives of Neurology
|November 21, 1998
PubMed

Insights

The ketogenic diet significantly reduced seizures in children with intractable epilepsy. This dietary therapy proved effective across multiple clinical settings, offering a viable treatment option.

Area of Science:

  • Neurology
  • Pediatric Epilepsy
  • Nutritional Therapy

Background:

  • Intractable epilepsy in children poses significant management challenges.
  • The ketogenic diet is a high-fat, adequate-protein, low-carbohydrate diet used therapeutically.

Purpose of the Study:

  • To evaluate the efficacy of the ketogenic diet in a multi-center study.
  • To assess seizure frequency reduction in pediatric patients with intractable epilepsy.

Main Methods:

  • Prospective study involving 51 children (aged 1-8 years) with intractable seizures.
  • Ketogenic diet initiated after hospitalization and fasting, followed for at least 6 months.
  • Seizure frequency monitored via parental calendars, compared to baseline at 3, 6, and 12 months.

Main Results:

  • At 6 months, 55% of children experienced at least a 50% decrease in seizure frequency.
  • At 1 year, 40% showed over a 50% seizure reduction, with 10% seizure-free.
  • Diet adherence was 88% at 3 months, decreasing to 47% at 1 year.

Conclusions:

  • The ketogenic diet is an effective intervention for reducing seizures in children with difficult-to-control epilepsy.
  • The diet can be successfully implemented in diverse clinical environments.
  • Treatment outcomes were not significantly influenced by patient demographics or EEG findings.
Abstract

Related Concept Videos

Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...